ARTG 461997ETHIZIA™ Hemostatic Sealing Patch - Gelatin/inorganic composite haemostatic agent
ARTG ID: 461997 · Johnson & Johnson Medical Pty Ltd · GATT Technologies BV · Class III · Started September 05, 2024
Good Name: Johnson & Johnson Medical Pty Ltd - ETHIZIA™ Hemostatic Sealing Patch - Gelatin/inorganic composite haemostatic agent
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 461997
- Start Date
- September 05, 2024
- Effective Date
- September 05, 2024
- Country
- Netherlands
- Address
- Transistorweg 5 6534 AT, Nijmegen
Intended for application by physicians as an aid to hemostatic sealing in internal organs during surgery, after standard surgical hemostatic techniques have been applied. The effect is local and primarily mechanical and is not dependent on the coagulation status of the patient. The product is not removed at the end of surgery but is resorbed in 4-6 weeks
Access comprehensive regulatory information for ETHIZIA™ Hemostatic Sealing Patch - Gelatin/inorganic composite haemostatic agent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 461997 and sponsored by Johnson & Johnson Medical Pty Ltd, manufactured by GATT Technologies BV in Netherlands. The device registration started on September 05, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.